Estrogen and cyproterone acetate combination-induced autoimmune hepatitis [2]

Journal of Clinical Gastroenterology

Volumn 35, Issue 1, 2002, Pages 98-100

  Kacar, Sabite ^a   Akdoǧan, Meral ^a   Koşar, Yasemin ^a   Parlak, Erkan ^a   Sasmaz, Nurgul ^a   Oǧuz, Perihan ^a   Aydoǧ, Gulden ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYPROTERONE ACETATE; ETHINYLESTRADIOL; LIVER ENZYME; PREDNISOLONE;

ACNE; ADOLESCENT; AUTOIMMUNE HEPATITIS; CASE REPORT; CHOLESTASIS; FEMALE; HIRSUTISM; HUMAN; LETTER; LIVER BIOPSY; LIVER FIBROSIS; LIVER INJURY; LIVER TOXICITY; PRIORITY JOURNAL;

EID: 0036083998     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200207000-00023     Document Type: Letter

References (10)

1. Drug induced hepatotoxicity. UCLA conference
2. Drug-induced liver diseases
3. Hepatobiliary complications of oral contraceptives
4. Estrogens stimulate proliferation of intrahepatic biliary epitelium in rats
5. Clinical and immunological study of 7 patients with minocycline-induced autoimmune phenomena
6. Tienilic acid-induced autoimmune hepatitis: Anti-liver and kidney microsomal type-2 autoantibodies recognize a three-site conformational epitope on cytochrome P4502C9
7. Antiandrogenic hepatotoxicity in patients with chronic viral hepatitis
8. Fatal fulminant hepatic failure due to cyproterone acetate
9. Hepatic insufficiency developing as a result of the flutamid treatment
10. Pediatric and adult forms of type 1 autoimmune hepatitis in Argentina: Evidence for differential genetic predisposition